Imaging molecular and cellular events in transplantation

Transplantation

Volumn 82, Issue 9, 2006, Pages 1124-1129

  George, Andrew J T ^a   Bhakoo, Kishore K ^a   Haskard, Dorian O ^a   Larkman, David J ^a   Reynolds, Peter R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Imaging; Magnetic resonance; Nuclear medicine; Optical; Positron emission tomography; Ultrasound

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

ACCURACY; ARTICLE; CELLULAR DISTRIBUTION; ECHOGRAPHY; GENE EXPRESSION; GENE THERAPY; HUMAN; IMAGE ENHANCEMENT; IMMUNOGENICITY; INFLAMMATION; IONIZING RADIATION; MOLECULAR IMAGING; MOLECULAR SIZE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SIGNAL NOISE RATIO; TRANSPLANTATION;

BIOLOGICAL MARKERS; DIAGNOSTIC IMAGING; GRAFT REJECTION; HUMANS; TRANSPLANTATION;

EID: 33751014839     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000235530.80305.d2     Document Type: Article

References (49)

1. Peters AM. Antibodies in Nuclear Medicine. In: George AJT, Urch CE, eds. Diagnostic and Therapeutic Antibodies. Totowa, NJ: Humana Press, 2000: 179.
2. George AJT. Monoclonal antibody therapy. In: Kaufman HFE, Steward MW, eds. Topley and Wilson's Microbiology and Microbial Infections. London: Hodder Arnold, 2005: 353.
3. Huston JS, George AJT, Adams GP, et al. Single-chain Fv radioimmunotargeting. Quart J Nuclear Med 1996; 40: 320.
4. Curtet C, Tellier C, Bohy J, et al. Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium- diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9. Proc Natl Acad Sci U S A 1986; 83(12): 4277.
5. Louie AY, Huber MM, Ahrens ET, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000; 18(3): 321.
6. Li WH, Parigi G, Fragai M, Luchinat C, Meade TJ. Mechanistic studies of a calcium-dependent MRI contrast agent. Inorg Chem 2002; 41(15): 4018.
7. Lund G, Wirtschafter JD, Nelson JD, Williams PA. Tattooing of eyelids: magnetic resonance imaging artifacts. Ophthalmic Surg 1986; 17(9): 550.
8. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988; 55(6): 1179.
9. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 1999; 10(2): 186.
10. Zhao M, Kircher MF, Josephson L, Weissleder R. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug Chem 2002; 13(4): 840.
11. Lewin M, Carlesso N, Tung CH, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18(4): 410.
12. Bhorade R, Weissleder R, Nakakoshi T, et al. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug Chem 2000; 11(3): 301.
13. Ahrens ET, Feili-Hariri M, Xu H, et al. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med 2003; 49(6): 1006.
14. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003; 228(2): 480.
15. Liang HD, Blomley MJ. The role of ultrasound in molecular imaging. Br J Radiol 2003; 76: S140.
16. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003; 9(1): 123.
17. Becker A, Hessenius C, Licha K, et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 2001; 19(4): 327.
18. Sato A, Klaunberg B, Tolwani R. In vivo bioluminescence imaging. Comp Med 2004; 54(6): 631.
19. Chen J, Tung CH, Mahmood U, et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002; 105(23): 2766.
20. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 2002; 8(7): 757.
21. Heelan BT, Osman S, Blyth A, et al. Use of 2-[18F]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography. Transplantation 1998; 66(8): 1101.
22. Ho C, Hitchens TK. A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ. Curr Pharm Biotechnol 2004; 5(6): 551.
23. Zhang Y, Dodd SJ, Hendrich KS, et al. Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration. Kidney Int 2000; 58(3): 1300.
24. Yang D, Ye Q, Williams M, et al. USPIO-enhanced dynamic MRI: evaluation of normal and transplanted rat kidneys. Magn Reson Med 2001; 46(6): 1152.
25. Ye Q, Yang D, Williams M, et al. In vivo detection of acute rat renal allograft rejection by MRI with USPIO particles. Kidney Int 2002; 61(3): 1124.
26. Beckmann N, Cannet C, Fringeli-Tanner M, et al. Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn Reson Med 2003; 49(3): 459.
27. Kanno S, Wu YJ, Lee PC, et al. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 2001; 104(8): 934.
28. Kanno S, Lee PC, Dodd SJ, et al. A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection. J Thorac Cardiovasc Surg 2000; 120(5): 923.
29. Johansson L, Johnsson C, Penno E, Bjornerud A, Ahlstrom H. Acute cardiac transplant rejection: detection and grading with MR imaging with a blood pool contrast agent- experimental study in the rat. Radiology 2002; 225(1): 97.
30. Dodd SJ, Williams M, Suhan JP, et al. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J 1999; 76(1 Pt 1): 103.
31. Kondo I, Ohmori K, Oshita A, et al. Leukocyte-targeted myocardial contrast echocardiography can assess the degree of acute allograft rejection in a rat cardiac transplantation model. Circulation 2004; 109(8): 1056.
32. Dodd CH, Hsu HC, Chu WJ, et al. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide- derived superparamagnetic nanoparticles. J Immunol Methods 2001; 256(1-2): 89.
33. Kircher MF, Allport JR, Graves EE, et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 2003; 63(20): 6838.
34. Chapman PT, Jamar F, Keelan ET, et al. Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum 1996; 39(8): 1371.
35. Weller GE, Lu E, Csikari MM, et al. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation 2003; 108(2): 218.
36. Kang HW, Josephson L, Petrovsky A, et al. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug Chem 2002; 13(1): 122.
37. Reynolds PJ, Larkman DJ, Haskard DO, et al. Detection of Vascular Expression of E-selectin in vivo by MR Imaging in Mice. Radiology; 2006, 10.1148/radiol.2412050490 (published online before print).
38. Sibson NR, Blamire AM, Bernades-Silva M, et al. MRI detection of early endothelial activation in brain inflammation. Magn Reson Med 2004; 51(2): 248.
39. Barber PA, Foniok T, Kirk D, et al. MR molecular imaging of early endothelial activation in focal ischemia. Ann Neurol 2004; 56(1): 116.
40. Jaffer FA, Weissleder R. Molecular imaging in the clinical arena. JAMA 2005; 293(7): 855.
41. Caus T, Kober F, Mouly-Bandini A, et al. (31)P MRS of heart grafts provides metabolic markers of early dysfunction. Eur J Cardiothorac Surg 2005; 28(4): 576.
42. Chu WC, Lam WW, Lee KH, et al. Phosphorus-31 MR spectroscopy in pediatric liver transplant recipients: a noninvasive assessment of graft status with correlation with liver function tests and liver biopsy. AJR Am J Roentgenol 2005; 184(5): 1624.
43. Niekisch MB, Von Elverfeldt D, Saman AE, et al. Improved pretransplant assessment of renal quality by means of phosphorus-31 magnetic resonance spectroscopy using chemical shift imaging. Transplantation 2004; 77(7): 1041.
44. Yoshikawa T, Suzuki Y, Kanashiro M, et al. Objective and rapid assessment of pancreas graft viability using 31P-nuclear magnetic resonance spectroscopy combined with two- layer cold storage method. Transplantation 2004; 78(1): 78.
45. Kuyama J, McCormack A, George AJT, et al. Indium-111 labelled lymphocytes: isotope distribution and cell division. Eur J Nucl Med 1997; 24(5): 488.
46. Bhakoo K, Chapon C, Jackson J, Jones W. Cell imaging. In: Webb, ed. Handbook of Modern Magnetic Resonance: Biological Sciences. New York: Springer, 2005.
47. Golzio M, Rols MP, Gabriel B, Teissie J. Optical imaging of in vivo gene expression: a critical assessment of the methodology and associated technologies. Gene Ther 2004; 11(Suppl 1): S85.
48. Shah K, Jacobs A, Breakefield XO, Weissleder R. Molecular imaging of gene therapy for cancer. Gene Ther 2004; 11(15): 1175.
49. Herschman HR. Noninvasive imaging of reporter gene expression in living subjects. Adv Cancer Res 2004; 92: 29.